13.8
İnhalasyon Anestezikleri: Genel Bakış
İnhalasyon anestezikleri, inhalasyon yoluyla genel anesteziyi indükleyen ilaçlardır. GABA_A reseptörlerinin hassasiyetini artırarak veya NMDA reseptör…
İnhalasyon anestezikleri, pulmoner alveoller ve dokular boyunca hızla yayılan solunan gazlar ve uçucu sıvılar yoluyla genel anesteziye neden olur.
Bu ajanların anestezik gücü minimum alveolar konsantrasyona bağlıdır. Bu anesteziklerin dağıtımı, alveolar yıkamayı ve ardından hızlı doku alımını içerir.
Dik doz-yanıt eğrileri ve bilinen antagonistleri olmayan dar terapötik indeksler sergilerler.
Modern ajanlar, izofluran, desfluran, sevofluran gibi uçucu sıvıları ve azot oksit gibi gazları kapsar. Yanıcı değildirler, patlayıcı değildirler ve atıkları en aza indirmek için bir devridaim sistemi ile teslim edilirler.
Bu ajanlar, NMDA reseptörlerini inhibe eden nitröz oksit hariç, GABA'nın GABAA reseptörleri üzerindeki etkisini artırarak serebrovasküler direnci ve solunum dürtüsünü azaltır.
Bu ajanların hipotansiyon, solunum yolu tahrişi ve nefrotoksisite gibi potansiyel yan etkileri vardır. Halojenli hidrokarbonlara maruz kalmak, nadir, yaşamı tehdit eden bir durum olan malign hipertermiyi tetikleyebilir.
Özellikle, çoğu inhalasyon anestezikleri atmosfere değişmeden salındığından, çevreyi ciddi şekilde etkilerler.
View the full transcript and gain access to JoVE Core videos
Q1: How do inhalational anesthetics induce general anesthesia?
Inhalational anesthetics induce general anesthesia through inhaled gases and volatile liquids that diffuse rapidly across pulmonary alveoli into tissues. Most agents enhance GABA's action on GABAA receptors, decreasing central nervous system activity. Nitrous oxide uniquely inhibits NMDA receptors instead. The depth of anesthesia can be rapidly adjusted by changing the inhaled gas concentration.
Q2: What is minimum alveolar concentration and why does it matter?
Minimum alveolar concentration (MAC) is the measure of anesthetic potency, determining how much inhaled anesthetic is needed for effect. It varies based on patient factors like age, temperature, and concurrent drug use. Agents with lower MAC values are more potent. This metric helps clinicians select appropriate anesthetics and dosing for individual patients.
Q3: What are the main types of modern inhalational anesthetics?
Modern inhalational anesthetics include volatile liquids such as isoflurane, desflurane, and sevoflurane, plus gases like nitrous oxide. Isoflurane causes dose-dependent hypotension with a pungent odor. Desflurane offers rapid onset and recovery due to low blood solubility. Sevoflurane has low pungency and is preferred for pediatric inhalation induction.
Q4: What adverse effects are associated with inhalational anesthetics?
Inhalational anesthetics can cause hypotension, respiratory irritation, and organ toxicity including nephrotoxicity. Exposure to halogenated hydrocarbons may trigger malignant hyperthermia, a rare but life-threatening condition. Metabolism can generate toxic metabolites, prompting replacement with less toxic alternatives. These risks require careful patient selection and monitoring during anesthesia.
Q5: Why are inhalational anesthetics a concern for the environment?
Most inhalational anesthetics are released unchanged into the atmosphere as greenhouse gases, contributing to global warming and climate change. Their environmental persistence and potency as climate agents have prompted efforts to minimize their use and atmospheric release. This environmental impact influences anesthetic selection in clinical practice.
Q6: How are inhalational anesthetics distributed and delivered in the body?
Inhalational anesthetics distribute through alveolar wash-in followed by rapid tissue uptake. They exhibit steep dose-response curves and narrow therapeutic indices ranging from 2 to 4, with no known antagonists. Modern agents are delivered via recirculation systems to minimize waste. This distribution pattern allows rapid onset and offset of anesthetic effects.
Q7: What factors influence the selection of a specific inhalational anesthetic?
Selection involves balancing the patient's pathophysiology against the drug's side-effect profile. Clinicians consider factors like age, temperature, concurrent medications, and the procedure duration. Sevoflurane is preferred for pediatric patients due to low pungency, while desflurane suits short procedures. The goal is maintaining optimal brain partial pressure while minimizing adverse effects.